According to Spero Therapeutics's latest financial reports the company's current revenue (TTM ) is £20.95 Million. a decrease over the revenue in the year 2023 that were of £75.93 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.